Nephros Inc (NEPH) · Oct 13, 2026 · Other events
Annual meeting scheduled — November 25 meeting; October 23 proposal deadline
Nephros scheduled its 2026 annual meeting for November 25 and set October 23 deadlines for proposals and alternative director nominees.
Nephros is a growing water-filtration company serving medical and commercial markets, with recent momentum in recurring programmatic revenue, services, and newer filtration applications. Its latest reported quarter reached record revenue of $6 million, while management highlighted expansion across medical and commercial water-safety products.
This filing does not change that operating story. It sets the 2026 annual meeting for November 25, 2026, more than five months after the prior annual meeting, and confirms the meeting will be held virtually.
The only practical significance is procedural: shareholder deadlines were reset. Proposals for inclusion in the proxy and notices supporting alternative director nominees must arrive by October 23, 2026. 〔0〕 The delayed meeting date reflects that it is more than 30 days beyond the anniversary of the June 16, 2025 meeting, rather than signaling a disclosed strategic or governance dispute. 〔1〕
Bottom line: This is routine shareholder-meeting housekeeping, not a new business catalyst. It matters mainly because October 23 is the deadline for any shareholder challenge or proposal to enter the proxy process; otherwise, the filing leaves Nephros’s growth narrative unchanged.
Definitive proxy statement and November 25 shareholder meeting
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!